Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
paracetamol + caffein + isometheptenmucat |
Is a |
Isometheptene mucate+acetaminophen |
false |
Inferred relationship |
Some |
|
|
paracetamol + caffein + isometheptenmucat |
Is a |
Product containing caffeine (medicinal product) |
false |
Inferred relationship |
Some |
|
|
paracetamol + caffein + isometheptenmucat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Xanthine |
false |
Inferred relationship |
Some |
|
|
paracetamol + caffein + isometheptenmucat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Paracetamol |
false |
Inferred relationship |
Some |
|
|
paracetamol + caffein + isometheptenmucat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Non-opioid analgesic (substance) |
false |
Inferred relationship |
Some |
|
|
paracetamol + caffein + isometheptenmucat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Stimulant (substance) |
false |
Inferred relationship |
Some |
|
|
paracetamol + caffein + isometheptenmucat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Isometheptene mucate (substance) |
false |
Inferred relationship |
Some |
|
|
paracetamol + caffein + isometheptenmucat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Caffeine |
false |
Inferred relationship |
Some |
|
|
paracetamol + caffein + isometheptenmucat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Phosphodiesterase inhibitor |
false |
Inferred relationship |
Some |
|
|
paracetamol + caffein + isometheptenmucat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Xanthine |
false |
Inferred relationship |
Some |
|
|
paracetamol + caffein + isometheptenmucat |
Is a |
Product containing isometheptene and paracetamol (medicinal product) |
false |
Inferred relationship |
Some |
|
|
paracetamol + caffein + isometheptenmucat |
Is a |
Product containing caffeine in oral dose form (medicinal product form) |
false |
Inferred relationship |
Some |
|
|
paracetamol + caffein + isometheptenmucat |
Has manufactured dose form |
Oral dose form |
false |
Inferred relationship |
Some |
|
|
paracetamol + caffein + isometheptenmucat |
Is a |
Product containing caffeine and paracetamol (medicinal product) |
false |
Inferred relationship |
Some |
|
|